Statistical analysis of a steady state study [PK / PD]

posted by H_Rotter – Germany, 2007-01-04 17:05 (6715 d 02:43 ago) – Posting: # 433
Views: 6,944

Hi MGR!

Have a look at Helmut's post.

Especially for drugs with low accumulation, BE for Cmin may be very difficult to demonstrate; if ever possible (safety/efficacy) you may try to apply a wider acceptance range for this parameter (but keep an eye on recent developments, which may prevent this...).

❝ And also please tell me the which procedure(ANOVA- Linear Model) and tests to be used for statistical analysis using SAS software.


I think we had this already.

Regards,
Hermann

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
27 visitors (0 registered, 27 guests [including 22 identified bots]).
Forum time: 20:49 CEST (Europe/Vienna)

There are many questions which fools can ask
that wise men cannot answer.    George Pólya

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5